Company intelligence / Profile preview

Copeland

Toronto, Ontario, Canadacopeland.com ↗

Ownership: Private
Development stage: Commercial

Overview

Copeland Biosciences developed proprietary CBD-based topical formulations delivered via a unique, FDA/Health Canada-cleared wearable device. The company claims extensive consultation/testing has led to optimal protocols for inflammatory pain relief. All products are compounded by licensed Canadian pharmacists. An internationally renowned medical advisory board supports ongoing research at a prestigious institution, but no published clinical trial results were found as of the last update.

Therapeutic areas: OtherImmunology
Modalities: Small moleculeDevice
Industry: Biotech

Beyond the preview

Go deeper on Copeland.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copeland.

Explore the full profile